Download file (1.42MB)
Download as zip (1.36MB)

コレクション

引用

説明:

Glioblastoma (GBM) is a highly malignant type of brain tumour that arises from astrocytes or supportive brain tissue in adults. Although there are several therapeutic options, recurrence rates remain high, with a 5 year survival rate expectancy of less than 10%. This study investigates nanofibre meshes that enable the long-term release of temozolomide (TMZ) over a 4 week period by controlling the fibre morphologies. The nanofibre meshes were fabricated via the electrospinning of a biodegradable polymer, poly(ε-caprolactone) (PCL). The obtained meshes were flexible and implantable as a local intracranial drug delivery platform. The nanofibre meshes also carry magnetic nanoparticles (MNPs) that enable the combined therapy of hyperthermia/chemotherapy corresponding to an alternating magnetic field (AMF). The heat generation behaviour of the nanofibre meshes was successfully adjusted in a hyperthermic temperature range (∼42.6 °C). The TMZ/MNP-loaded nanofibre meshes showed a 76% reduction in the cell viability of GBM cancer (T98G) cells through the synergistic effect of hyperthermia and chemotherapy. These results indicated the potential applications of nanofibre meshes as an implantable intracranial drug delivery system as an adjunct to surgery and radiation for GBM patients.

権利情報:

• In Copyright
  

キーワード: nanofibers, glioblastoma , cancer , chemotherapy

刊行年月日: 2023-02-21

出版者: Royal Society of Chemistry (RSC)

掲載誌:

• New Journal of Chemistry (ISSN: 13699261) vol. 47 issue. 12 p. 5816-5824

研究助成金:

• Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) [JP19H04476]
• Japan Society for the Promotion of Science Grant-in-Aid for Transformative Research Areas (A) [JP20H05877]

原稿種別: 著者最終稿 (Accepted manuscript)

MDR DOI: https://doi.org/10.48505/nims.4836

公開URL: https://doi.org/10.1039/d3nj00534h

関連資料:

その他の識別子:

連絡先:

更新時刻: 2024-10-11 12:30:30 +0900

MDRでの公開時刻: 2024-10-11 12:30:30 +0900